Understanding why some patients don't respond to cognitive behavioral therapy for anxiety
Contributions of Self-Focused Attention to Early Warning Indicators of CBT Non-Response
This study is looking into why some people with anxiety and obsessive-compulsive disorders don’t get better with cognitive behavioral therapy (CBT), and it hopes to find clues that can help doctors personalize treatment for those who might have a harder time with it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11115730 on NIH RePORTER |
What this research studies
This research investigates the reasons behind why some patients do not respond to cognitive behavioral therapy (CBT) for anxiety and obsessive-compulsive disorders. It aims to identify early warning signs of non-response by examining various clinical, behavioral, and neural measurements before, during, and after treatment. By utilizing advanced machine learning techniques, the study will analyze data to find a specific biomarker related to self-focused attention that could predict treatment outcomes. This could help tailor interventions for patients who may struggle with CBT.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with anxiety or obsessive-compulsive disorders who are beginning cognitive behavioral therapy.
Not a fit: Patients who are not undergoing cognitive behavioral therapy or those with conditions unrelated to anxiety or obsessive-compulsive disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients who are at risk of not responding to CBT.
How similar studies have performed: Previous research has shown promise in identifying biomarkers related to treatment response, suggesting that this approach may yield valuable insights.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Fang, Angela — University of Washington
- Study coordinator: Fang, Angela
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.